SWOG clinical trial number
SWOG-8957

Feasibility Trial of Postoperative Radiotherapy + Cisplatin Followed by Three Courses of 5-FU + Cisplatin in Patients with Resected Head and Neck Cancer

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Feasibility Trial of Postoperative Radiotherapy + Cisplatin Followed by Three Courses of 5-FU + Cisplatin in Patients with Resected Head and Neck Cancer
Activated
05/01/1990
Closed
05/01/1992

Research committees

Head and Neck Cancer

Publication Information Expand/Collapse

1999

Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study

JA Kish;JK Benedetti;SP Balcerzak;RW Veith;R Davis;TW Pollock;DE Schuller;JF Ensley Cancer Journal from Scientific American 5(5):307-311

1993

Post operative adjuvant treatment of advanced head and neck cancer. Wayne State University experience and Southwest Oncology Group feasibility trial.

JA Kish;J Ensley;J Benedetti;D Schuller;M Al-Sarraf ASCO 12:285(#923)

1992

Post-operative radiotherapy + cisplatin followed by three courses 5-fluorouracil + cisplatin in resected head and neck cancer patients - preliminary report. A Southwest Oncology Group study.

JA Kish;JF Ensley;D Schuller;J Kinzie;B Metch AACR 33:225(#1346)